BCL2 and breast carcinoma: MiR-16-5p was among the first downregulated miRNAs identified in chronic lymphocytic leukemia due to frequent deletions [40] and moreover gained wider attention as a regulator of anti-apoptotic BCL2 in prostate and breast cancer [41,42] as well as breast cancer development [43].